Toshiba changes include Sharma's exit
Several personnel changes took place at Toshiba America MedicalSystems last month, including the departure of vice presidentof corporate marketing Ravi Sharma. Toshiba, of Tustin, CA, declinedto comment on the reasons for Sharma's exit other than to
Several personnel changes took place at Toshiba America MedicalSystems last month, including the departure of vice presidentof corporate marketing Ravi Sharma. Toshiba, of Tustin, CA, declinedto comment on the reasons for Sharma's exit other than to sayhe left to pursue other interests. Sharma joined the company in1989 and held the position for two years.
Other changes at the company were on a brighter note. SuzanneCertain was named director of ultrasound marketing and Dean Winterwas tapped as director of ultrasound national sales. The promotionsdenote their assumption of additional responsibilities after theexit of Philip Smith, who headed the ultrasound business unituntil leaving Toshiba in April (SCAN 4/12/95).
In nuclear medicine, Steve Sickels' title has been changed todirector of the nuclear medicine business unit. The promotionreflects his authority over Toshiba's nuclear medicine softwaredevelopment group, which will be moved from Japan to Toshiba AmericaMRI headquarters in South San Francisco, CA (SCAN 7/6/95).
In addition, Tom Bogle was named vice president of full linesales, overseeing sales for the CT, MRI, nuclear medicine, vascularand general x-ray product lines, as well as Toshiba's full-linestrategic accounts department.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
